David J. Tunnicliffe

4.5k total citations · 1 hit paper
69 papers, 1.2k citations indexed

About

David J. Tunnicliffe is a scholar working on Nephrology, Rheumatology and Genetics. According to data from OpenAlex, David J. Tunnicliffe has authored 69 papers receiving a total of 1.2k indexed citations (citations by other indexed papers that have themselves been cited), including 20 papers in Nephrology, 16 papers in Rheumatology and 14 papers in Genetics. Recurrent topics in David J. Tunnicliffe's work include Genetic and Kidney Cyst Diseases (12 papers), Renal Diseases and Glomerulopathies (9 papers) and Dialysis and Renal Disease Management (9 papers). David J. Tunnicliffe is often cited by papers focused on Genetic and Kidney Cyst Diseases (12 papers), Renal Diseases and Glomerulopathies (9 papers) and Dialysis and Renal Disease Management (9 papers). David J. Tunnicliffe collaborates with scholars based in Australia, New Zealand and Italy. David J. Tunnicliffe's co-authors include Jonathan C. Craig, Allison Tong, Davinder Singh‐Grewal, Suetonia C. Palmer, Giovanni FM Strippoli, Siah Kim, Gopala K. Rangan, Sean O’Neill, Marcello Tonelli and Martin Howell and has published in prestigious journals such as Annals of Internal Medicine, Cochrane Database of Systematic Reviews and Kidney International.

In The Last Decade

David J. Tunnicliffe

57 papers receiving 1.1k citations

Hit Papers

1 papers align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Executive summary of the KDIGO 2021 Clinical Practice Guideline for the Management of Blood Pressure in Chronic Kidney Disease

2021 176 citations Alfred K. Cheung, Tara I. Chang et al. profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
David J. Tunnicliffe Australia	18	323	290	145	139	135	69	1.2k
Serhan Tuğlular Türkiye	17	148 0.5×	300 1.0×	46 0.3×	84 0.6×	77 0.6×	96	986
Margaret Hastings United States	18	119 0.4×	571 2.0×	52 0.4×	201 1.4×	192 1.4×	38	1.5k
Dong Chan Jin South Korea	26	84 0.3×	959 3.3×	83 0.6×	102 0.7×	81 0.6×	78	2.0k
Lavjay Butani United States	20	105 0.3×	333 1.1×	53 0.4×	75 0.5×	60 0.4×	105	1.2k
Annette de Thurah Denmark	24	882 2.7×	66 0.2×	46 0.3×	232 1.7×	207 1.5×	99	1.8k
Jonas Höijer Sweden	25	55 0.2×	99 0.3×	102 0.7×	111 0.8×	70 0.5×	68	1.5k
Elizabeth H. Jones United Kingdom	12	91 0.3×	477 1.6×	73 0.5×	72 0.5×	28 0.2×	39	1.2k
Sharon Nessim United States	21	392 1.2×	104 0.4×	45 0.3×	115 0.8×	214 1.6×	33	1.5k
Fiona Mackie Australia	19	82 0.3×	274 0.9×	111 0.8×	23 0.2×	58 0.4×	53	1.3k
Fung Chang Sung Taiwan	23	66 0.2×	160 0.6×	44 0.3×	162 1.2×	27 0.2×	52	1.3k

Countries citing papers authored by David J. Tunnicliffe

Since Specialization

Citations

This map shows the geographic impact of David J. Tunnicliffe's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by David J. Tunnicliffe with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites David J. Tunnicliffe more than expected).

Fields of papers citing papers by David J. Tunnicliffe

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by David J. Tunnicliffe. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by David J. Tunnicliffe. The network helps show where David J. Tunnicliffe may publish in the future.

Co-authorship network of co-authors of David J. Tunnicliffe

This figure shows the co-authorship network connecting the top 25 collaborators of David J. Tunnicliffe. A scholar is included among the top collaborators of David J. Tunnicliffe based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with David J. Tunnicliffe. David J. Tunnicliffe is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Cumpston, Miranda, Kelvin Hill, Steve McDonald, et al.. (2025). Methods for living guidelines: paper 6: insights from Australian Living Evidence Collaboration's (ALEC) use of existing systematic reviews in living guideline development. Journal of Clinical Epidemiology. 187. 111812–111812.

Wu, Rebecca, Nicole Scholes‐Robertson, Anita van Zwieten, et al.. (2025). Reporting the involvement of patients and caregivers in identifying and designing healthcare interventions: the IDEAS framework. Journal of Clinical Epidemiology. 183. 111784–111784. 2 indexed citations

Natale, Patrizia, et al.. (2025). Thiazolidinediones for people with chronic kidney disease and diabetes. Cochrane Database of Systematic Reviews. 2025(11). CD015907–CD015907.

Bagchi, Soumita, Giovanni FM Strippoli, Patrizia Natale, et al.. (2025). Pharmacological interventions in IgA nephropathy: protocol for a living systematic review and network meta-analysis. BMJ Open. 15(8). e106553–e106553.

O’Neill, Niamh, David W. Johnson, Aisling Kelly, et al.. (2025). A methodology for determining dosing recommendations for anticancer drugs in patients with reduced kidney function. EClinicalMedicine. 82. 103101–103101.

Tunnicliffe, David J., Heath White, & Tari Turner. (2025). Living guidelines have come of age: new insights and methods—an open call for contributions. Journal of Clinical Epidemiology. 187. 111968–111968.

Bose, Bhadran, Simon Carter, Nicole Scholes‐Robertson, et al.. (2025). CARI Guidelines Commentary on the KDIGO Clinical Practice Guideline for the Management of Glomerular Diseases. Nephrology. 30(9). e70119–e70119.

Agarwal, Arnav, Xiaoxi Zeng, Sheyu Li, et al.. (2024). Sodium-glucose cotransporter-2 (SGLT-2) inhibitors for adults with chronic kidney disease: a clinical practice guideline. BMJ. 387. e080257–e080257. 8 indexed citations

Bolignano, Davide, Carmine Zoccali, Marinella Ruospo, et al.. (2024). Interventions for preventing the progression of autosomal dominant polycystic kidney disease. Cochrane Database of Systematic Reviews. 2024(10). CD010294–CD010294. 2 indexed citations

10.

Cooper, Tess E, et al.. (2024). Education programmes for people with chronic kidney disease and diabetes. Cochrane Database of Systematic Reviews. 2024(8). CD007374–CD007374. 4 indexed citations

11.

Walker, Curtis, et al.. (2024). Management of chronic kidney disease for Māori in Aotearoa New Zealand: a summary of clinical practice guidelines. New Zealand Medical Journal. 137(1594). 62–68. 1 indexed citations

12.

Tunnicliffe, David J., et al.. (2023). CARI guidelines: Culturally safe and clinical kidney care for First Nations Australians – A summary. 19(2).

13.

Tomson, Charles, Alfred K. Cheung, Johannes F.E. Mann, et al.. (2021). Management of Blood Pressure in Patients With Chronic Kidney Disease Not Receiving Dialysis: Synopsis of the 2021 KDIGO Clinical Practice Guideline. Annals of Internal Medicine. 174(9). 1270–1281. 36 indexed citations

14.

Scholes‐Robertson, Nicole, Martin Howell, Talia Gutman, et al.. (2020). Patients’ and caregivers’ perspectives on access to kidney replacement therapy in rural communities: systematic review of qualitative studies. BMJ Open. 10(9). e037529–e037529. 23 indexed citations

15.

Sumpton, Daniel, Ayano Kelly, David J. Tunnicliffe, et al.. (2018). AB1237 Patients' perspectives and experience of psoriasis and psoriatic arthritis: a systematic review and thematic synthesis of qualitative studies. Annals of the Rheumatic Diseases. 77. 1715–1715.

16.

Tunnicliffe, David J., Vivek Thakkar, Davinder Singh‐Grewal, et al.. (2016). Patients’ Perspectives and Experiences Living with Systemic Sclerosis: A Systematic Review and Thematic Synthesis of Qualitative Studies. The Journal of Rheumatology. 43(7). 1363–1375. 55 indexed citations

17.

Lee, Vincent, David J. Tunnicliffe, & Gopala K. Rangan. (2015). KHA-CARI Autosomal Dominant Polycystic Kidney Disease Guideline: Management of End-Stage Kidney Disease. Seminars in Nephrology. 35(6). 595–602.e12. 2 indexed citations

18.

Tchan, Michel, Judy Savige, Chirag Patel, et al.. (2015). KHA-CARI Autosomal Dominant Polycystic Kidney Disease Guideline: Genetic Testing for Diagnosis. Seminars in Nephrology. 35(6). 545–549.e2. 6 indexed citations

19.

Tong, Allison, Gopala K. Rangan, Marinella Ruospo, et al.. (2015). A painful inheritance—patient perspectives on living with polycystic kidney disease: thematic synthesis of qualitative research. Nephrology Dialysis Transplantation. 30(5). 790–800. 39 indexed citations

20.

Rangan, Gopala K., et al.. (2015). KHA-CARI Autosomal Dominant Polycystic Kidney Disease Guideline: Screening for Polycystic Kidney Disease. Seminars in Nephrology. 35(6). 557–564.e6. 5 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact